Ticker Details
Absci Corporation Common Stock
IPO Date:	July 22, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.41B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 5.00%
Avg Daily Range (30 D):	$0.43 | 4.84%
Avg Daily Range (90 D):	$0.34 | 5.36%

Institutional Daily Volume
Avg Daily Volume:	1.91M
Avg Daily Volume (30 D):	4.93M
Avg Daily Volume (90 D):	4.71M

Trade Size
Avg Trade Size (Sh.):	170
Avg Trade Size (Sh.) (30 D):	109
Avg Trade Size (Sh.) (90 D):	138

Institutional Trades
Total Institutional Trades:	470
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$2.56M
Avg Institutional Trade (90 D):	$1.88M
Avg Institutional Trade Volume:	.34M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$4.75M
Avg Closing Trade (90 D):	$2.68M
Avg Closing Volume:	401.13K

News

Jun 16, 2026 @ 12:45 PM The Quiet Bottleneck in AI Drug Discovery Isn't th... Source: Equity Insider

May 13, 2026 @ 2:03 PM AMD Reveals A $6.5 Million Marvell Bet That's Alre... Source: Erica Kollmann

May 5, 2026 @ 12:11 AM Absci Announces Inducement Grant Under Nasdaq List... Source: Na

Mar 3, 2026 @ 1:00 PM Absci Strengthens Clinical Leadership with Appoint... Source: Na

Oct 29, 2025 @ 8:05 PM Absci to Report Business Updates and Third Quarter... Source: Globe Newswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.19	$-.19	$-.84
Diluted EPS	$-.19	$-.19	$-.84
Revenue	$.22M	$.65M	$2.8M
Gross Profit
Net Income / Loss	$-29.6M	$-29.56M	$-115.18M
Operating Income / Loss	$-30.85M	$-31.04M	$-120.32M
Cost of Revenue
Net Cash Flow	$-11.39M	$-5.79M	$-37.14M
PE Ratio